J Oral Med Oral Surg
Volume 26, Number 3, 2020
|Number of page(s)||7|
|Section||Article original / Original article|
|Published online||26 August 2020|
Could methylene blue be used to manage burning mouth syndrome? A pilot case series
Service de Physiologie, Département d'Odontologie, Université Cheikh Anta Diop, Dakar, Senegal
2 Service de Médecine Bucco-Dentaire, Hôpital Bretonneau Paris, AP-HP, France
3 Université de Paris, LabNOF (EA 7543), 75006 Paris, France
4 Service d'Odontologie, Hôpital Rothschild, AP-HP, Paris, France
5 Service d'Odontologie, Groupe hospitalier Pitié-Salpêtrière, AP-HP, Paris, France
* Correspondence: firstname.lastname@example.org
Accepted: 12 January 2020
Objective: Burning mouth syndrome is a disabling condition of complex pathophysiology characterized by spontaneous pain felt in the oral mucosa in the absence of evident mucosal lesions which lacks efficient treatments to this day. The purpose of this study was to demonstrate the efficacy of methylene blue in the management of burning mouth syndrome. Methods: The study was conducted at the dental clinic of the Anta Diop University and Newtown dental clinic of Dakar, Senegal. A solution of methylene blue as a mouth-rinse (0.5%) was applied for 5 minutes in five patients satisfying the ICHD-3 diagnostic criteria for burning mouth syndrome. This procedure was repeated every 6 hours 3 times per 24h, during 7 days. Using numeric rating scale, pain severity was assessed as the mean pain felt during the last day of application. Results: After 7 days, the pain was significantly reduced by two-thirds and almost absent at 3 and 6 months follow-up. No secondary effects of the use of methylene blue were observed. Putative mechanisms of action and potential implications for treatment are discussed. Conclusion: Methylene blue is an old compound but a novel topical therapy that could prove beneficial in the management of burning mouth syndrome.
Key words: Trigeminal pain / orofacial nociception / neuropathy / glossodynia / stomatodynia / methylthioninium chloride
© The authors, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.